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We investigated the function of severely truncated simian immunodeficiency virus (SIV) Nef proteins (tNef)
in vitro and in vivo. These variants emerged in rhesus monkeys infected with SIVmac239 containing a 152-bp
deletion in the nef-unique region and have been suggested to enhance SIV virulence (E. T. Sawai, M. S. Hamza,
M. Ye, K. E. Shaw, and P. A. Luciw, J. Virol. 74:2038-2045, 2000). We found that the tNef proteins were unable
to down-regulate the cell surface expression of major histocompatibility complex class I proteins, CD4, and
CD28 and neither stimulated SIV replication nor enhanced virion infectivity. The tNef proteins did efficiently
down-regulate T-cell receptor (TCR):CD3 cell surface expression. Nevertheless, the SIVmac239 tnef variants
were strongly attenuated in six infected juvenile rhesus macaques. Thus, while the ability of SIV Nef to
down-modulate TCR:CD3 cell surface expression apparently confers a selective advantage in vivo, it is
insufficient for efficient viral replication in infected macaques. Additional mutations elsewhere in SIVmac239
tnef genomes are required for a virulent phenotype.
The 792-bp nef gene of the pathogenic simian immunodefi-
ciency virus mac239 clone (SIVmac239) encodes a myristylated
protein of approximately 34 kDa that down-regulates the cell
surface expression of CD3, CD4, CD28, and major histocom-
patibility class I (MHC-I) molecules, enhances viral replica-
tion, increases the infectivity of viral particles, and associates
with the p21-regulated protein serine kinase PAK2 (10–13, 16,
17, 23–25). These multiple functions of 239wt Nef are geneti-
cally separable and require distinct elements located through-
out the Nef molecule.
Nef is important for efficient viral replication and the per-
sistence of HIV and SIV in vivo (7, 13–15). Adult or juvenile
rhesus macaques inoculated with a variant of the pathogenic
SIVmac239 clone containing a deletion of 182 bp in the nef
gene (nef182) (Fig. 1) usually exhibit low viral loads, and the
majority of infected animals do not progress to immunodefi-
ciency (13). These results provided the basis for the design and
evaluation of live attenuated SIV vaccines with deletions in
accessory genes (6).
Recently, it was found that uncloned SIVmac239 variants
expressing truncated Nef (tNef) proteins of about 25 kDa are
pathogenic in infected rhesus macaques (20). These variants
emerged in animals infected with recombinant SIVmac239 vi-
ruses containing a missense mutation of the Nef initiator me-
thionine, combined with either a 152-bp deletion in the nef-
unique region or an insertion of the interleukin-2 (IL-2) cDNA
in place of the 152-bp deletion, both of which introduced
frameshifts into the nef open reading frame (ORF) (Fig. 1). In
the reverted tnef alleles, the nef ATG initiation codon was
restored and frameshift mutations were repaired to restore
contiguous, albeit truncated, nef ORFs (tnef24 and tnef46)
(Fig. 1) (20). The tNef proteins lack an approximately 50-
amino-acid-long region overlapping the highly conserved core
of the Nef protein. This deletion spans elements mediating
functional interactions of Nef with clathrin adaptor complexes
that are required for the down-regulation of CD4 and CD28,
as well as elements required for Nef to associate with PAK2
activity (4, 16, 18). Therefore, it was surprising that the tNef
proteins were linked to a pathogenic phenotype.
The emergence of variant viruses containing a restored tnef
ORF indicated that the severely truncated tNef proteins
(tNef24 and tNef46) contained some residual function. To
identify this function, we constructed truncated 239nef alleles,
tnef.1 and tnef.2, corresponding to those previously recovered
from the progressing animals 29810-24 and 27021-46N, respec-
tively (20). The mutant tnef.1 and tnef.2 alleles were generated
by splice overlap extension PCR and cloned into both a
bicistronic vector coexpressing GFP (pCGCG.tNef.1 and
pCGCG.tNef.2) and a proviral SIVmac239 construct essen-
tially as described previously (12, 19). Flow cytometry analysis
of Jurkat T cells transiently transfected with the bicistronic
vectors (9, 11, 12) revealed that, in contrast to 239wt Nef, the
tNef.1 and tNef.2 proteins did not decrease the cell surface
expression of CD4, CD28, and MHC-I molecules (Fig. 2) (data
not shown). However, both tNef forms down-regulated the
cell surface expression of the T-cell receptor (TCR):CD3
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complex as efficiently as 239wt Nef (Fig. 2) (data not shown).
Down-modulation of TCR:CD3 is a conserved function of
SIVmac239 and HIV-2 Nef proteins (2, 10, 21).
To test the ability of the tNefs to stimulate SIV replication
and particle infectivity, virus stocks were generated in 239T
cells transiently transfected with the respective wild-type and
mutant proviral genomes (8). As expected (16), no significant
differences in the replication kinetics of SIVmac239 viruses
containing the 239wt nef, tnef.1, and tnef.2 alleles were ob-
served in CEMx174 cells (Fig. 3A). Western blot analysis re-
vealed that CEMx174 cells infected with the SIVmac239 vari-
ants expressed tNef proteins of the expected size of about 25
kDa (data not shown). Infection of rhesus macaque peripheral
blood mononuclear cells (rhPBMC) (Fig. 3B) and the herpes-
FIG. 1. Amino acid sequence alignment of SIVmac239 wild-type and variant Nef proteins. Amino acid sequences surrounding the deleted
regions are shown for Nef152 and Nef182; the truncated Nef proteins that emerged in vivo in macaque 29810-24 (tNef24) or in macaque
27071-46N (tNef46); the tNef proteins modeled on tNef24 and tNef46 used in this work (tNef.1 and tNef.2, respectively); and Nef153 and Nef183,
resulting from repair of frameshift mutations in nef152 and nef182. Dots represent identical amino acids, dashes represent missing amino acids,
and asterisks represent premature in-frame termination codons introduced by frameshift mutations.
FIG. 2. The SIVmac239 tNef.1 protein retains the ability to down-regulate TCR:CD3 cell surface expression. Jurkat T cells were transiently
transfected with a control plasmid expressing green fluorescent protein (GFP) alone (left panels) or with plasmids coexpressing GFP and 239nef*,
239wt Nef (middle panels), or tNef.1 (right panels). 239nef* contains a premature in-frame TAA stop signal at the 93rd codon of nef (13).
Expression of CD4, MHC-I, CD28, CD3, and GFP was analyzed by two-color flow cytometry as described previously (9, 11, 12). Similar results
were obtained in two independent experiments.
VOL. 76, 2002 NOTES 12361
 o
n







virus saimiri-transformed macaque T-cell line 221 (Fig. 3C) (1)
demonstrated that, in contrast to the 239wt nef allele, the tnef.1
and tnef.2 alleles were unable to stimulate SIVmac239 repli-
cation. Additionally, the tNef proteins did not increase virion
infectivity (Fig. 3D).
Of the six in vitro Nef activities investigated, the only one
retained by the tNef proteins was the ability to down-regulate
TCR:CD3. Therefore, the previous suggestion that the se-
verely truncated tNef proteins were capable of significantly
increasing SIV virulence in rhesus macaques was surprising
(20). However, in this study, virus was recovered from the
progressing animal, 26939-105N, near necropsy, leaving the
possibility that mutations elsewhere in the viral genome might
have contributed to the virulent phenotype.
To address this possibility, six juvenile rhesus macaques were
inoculated intravenously with SIVmac239 tnef.1 virus stock
containing 5 ng of p27 produced from transiently transfected
293T cells as described previously (8). The animals were
healthy and seronegative for SIV, D-type retroviruses, and
STLV-1 at the time of infection. Sera and PBMCs were col-
lected from the infected rhesus monkeys at regular intervals.
Serological, virological, and immunological analyses of the
clinical samples were performed as described before (22, 23,
26). As shown in Fig. 4, following initial spikes in the acute
phase, the viral RNA copy numbers and cell associated viral
loads were low in all six animals infected with SIVmac239
tnef.1 compared to those infected with wild-type SIVmac239.
In agreement with the observed attenuated in vivo replication
of SIVmac239 tnef.1, the total CD4 T cells and CD4 CD29
memory T cells were essentially unchanged in the infected
animals (Fig. 5), all of whom remained healthy throughout the
40-week observation period. Thus, the SIVmac239 tnef.1 allele
FIG. 3. Infectivity and replication of the SIVmac239 tnef.1 and tnef.2 variants. Stocks of SIVmac239 containing wild type (wt), prematurely
terminated (239nef*), or tnef.1 and tnef.2 variants were generated in 293T cells. Replication of the wild-type and variant viruses in CEMx174 cells
(A), rhPBMCs (B), and 221 cells in the absence of IL-2 (C) is shown. Cells were infected with aliquots of virus stocks containing 5 ng of p27.
PBMCs were infected immediately after isolation and stimulated 3 days later as described previously (16, 19). The amount of p27 antigen was
determined by an SIV/HIV-2 enzyme-linked immunosorbent assay (ELISA) obtained through the AIDS Research and Reference Reagent
Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Reverse transcriptase (RT) activity
was determined with a phosphorimager by photon-stimulated light emission (P.S.L.). The infectivity of wild-type and variant SIV to P4-CCR5 cells
(5) infected with virus stocks containing 50 ng of p27 was determined as described previously (19), and is shown in panel D. All results are
representative of three to five experiments performed with several independently produced virus stocks.
FIG. 4. Replication of the SIVmac239 tnef.1 variant is attenuated in vivo. The cell-associated viral load (A) and the viral RNA load (B) in
Mm10287 (Œ), Mm10295 (‚), Mm10302 (}), Mm10663 (), Mm10672 (F), and Mm10677 (E) infected with the SIVmac239 tnef.1 variant are
shown. For comparison, average values obtained from four rhesus macaques infected with SIVmac239 NU () and eight who received wild-type
SIVmac239 () are also shown. The detection limit for viral RNA of approximately 40 copies per ml (26) is indicated by a dotted line.
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was severely attenuated, and the infections were well con-
trolled in all animals.
Intact but truncated tnef ORFs were independently restored
in several animals infected with SIVmac239 variants containing
the 152-bp deletion (20), yet this was never observed in ma-
caques infected with an SIVmac239 variant containing a
182-bp deletion (13, 14). Both deletions start at nucleotide
position 172 of the nef ORF (13, 20). However, in contrast to
the 152-bp deletion, the 182-bp deletion removes nucleotides
encoding amino acids 111 to 120 of the Nef protein (see Fig. 1).
This suggested that amino acids 111 to 120 might be required
to down-regulate TCR:CD3 cell surface expression. To ad-
dress this possibility, the frameshift mutations introduced by
the 152- and 182-bp deletions were repaired by removing an
additional single nucleotide in the respective nef ORFs. The
resulting nef variants (nef153 and nef183, see Fig. 1) were
expressed transiently in Jurkat T cells. As shown in Fig. 6,
Nef153 down-modulated the cell surface expression of TCR:
CD3. In contrast, Nef183 was not able to down-modulate
TCR:CD3 (Fig. 6), and was also defective in all other in vitro
assays of Nef functions tested (data not shown). Thus, a selec-
tive pressure for TCR:CD3 down-regulation may explain why
the truncated Nef proteins emerged only in animals infected
with SIVmac239 containing the 152-bp deletion in the nef-
unique region. This event was not possible in animals infected
with SIVmac239 containing the 182-bp deletion because it
removed amino acids required for TCR:CD3 downregulation.
In summary, there are two novel implications of this
work. First, it is evident that TCR:CD3 down-regulation by
SIVmac239 Nef is associated with a selective advantage for the
virus in vivo. However, this function alone is insufficient for
high viral loads and rapid disease induction by SIVmac239 in
infected rhesus macaques. This is consistent with recent evi-
dence suggesting that a combination of several independent
Nef functions allows SIVmac239 and HIV-1 to replicate effi-
ciently in the infected host (3, 5, 12, 19). Second, our data
imply that changes elsewhere in the viral genome are required
for a pathogenic phenotype of SIVmac239 expressing the tNef
proteins. It will be important to determine the nature of such
alterations in the SIVmac genome that can compensate for the
loss of other Nef functions.
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